ASAGI Labs

ASAGI Labs is a Japanese biotechnology company specializing in the discovery and development of therapeutic antibodies targeting G protein-coupled receptors (GPCRs). The company utilizes its proprietary ASAGI platform, which integrates advanced protein engineering and structural biology to overcome traditional challenges in membrane protein drug discovery. By stabilizing GPCRs in their native conformations, ASAGI Labs facilitates the identification of high-affinity monoclonal antibodies for complex targets. Their pipeline primarily focuses on oncology and inflammatory conditions, aiming to address significant unmet medical needs through precision biologics. The company operates as a platform-driven biotech, engaging in both internal program development and strategic collaborations. As a spin-off from Kyoto University, it leverages deep academic expertise in cryo-electron microscopy and protein science.